Biomaterial Database

Hydralazine elimination in man. 1973

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

UI	MeSH Term	Description	Entries
D007275	Injections, Intravenous	Injections made into a vein for therapeutic or experimental purposes.	Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007538	Isoniazid	Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.	Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D010641	Phenotype	The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.	Phenotypes
D002854	Chromatography, Paper	An analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper (stationary phase) by their varied degree of solubility/mobility in the eluting solvent (mobile phase).	Paper Chromatography,Chromatographies, Paper,Paper Chromatographies
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D003622	Dapsone	A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8)	Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl
D005470	Fluorometry	An analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS.	Fluorimetry,Fluorometric Analysis,Analysis, Fluorometric
D005965	Glucuronates	Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure.	Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D006207	Half-Life	The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity.	Halflife,Half Life,Half-Lifes,Halflifes
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

Kinetics of hydralazine elimination.

June 1977, Clinical pharmacology and therapeutics,

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

Studies on hydralazine. III. Bioavailability of hydralazine in man.

January 1976, European journal of clinical pharmacology,

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

Metabolism of hydralazine in man.

January 1977, Arzneimittel-Forschung,

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

Electrophysiologic properties of hydralazine in man.

September 1980, Pacing and clinical electrophysiology : PACE,

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

From hydralazine to CGRP to man?

January 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group,

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

Site of action of hydralazine and dihydralazine in man.

January 1959, Acta pharmacologica et toxicologica,

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

Effect of hydralazine on the elimination of antipyrine in the rat.

December 1987, Pharmaceutical research,

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

Elimination of TRH in man.

September 1972, The Journal of clinical endocrinology and metabolism,

M M Reidenberg, and D Drayer, and A L DeMarco, and C T Bello

Elimination of amines in man.

October 1938, The Biochemical journal,